natur
pathogen
plethora
antigen
compris
ten
hundr
potenti
epitop
certainli
antigen
epitop
equal
use
gener
protect
immun
also
assum
individu
mount
strong
hightit
respons
potenti
epitop
fact
complex
antibodi
individu
polyclon
serum
correspond
rel
limit
collect
epitop
may
necessarili
includ
import
protect
thu
creat
cocktail
defin
epitop
select
abil
afford
proven
protect
one
abl
focu
immun
system
gener
prefer
repertoir
antibodi
hand
pick
job
within
divers
antigen
epitop
pathogen
equal
abil
elicit
antibodi
product
often
find
epitop
seem
domin
strong
respons
toward
may
expens
abl
respond
epitop
pathogen
one
thing
certain
domin
epitop
necessarili
correspond
effect
neutral
one
fact
natur
select
pressur
tend
drive
occlus
neutral
epitop
pathogen
pathogen
gain
select
advantag
abl
obscur
weak
point
distract
host
immun
system
devis
seduct
epitop
littl
protect
valu
achiev
creat
bait
sort
particularli
surfaceaccess
hydrophil
yet
amen
constant
genet
variat
exampl
five
variabl
loop
highli
immunogen
ever
chang
natur
allow
swarm
hiv
evad
immun
surveil
constantli
mutat
bind
capac
antibodi
produc
first
encount
epitopebas
vaccin
would
contribut
overcom
problem
envisag
epitop
would
select
abil
elicit
potent
neutral
rather
natur
surfac
access
epitop
like
correspond
conserv
aspect
pathogen
toler
modif
natur
select
evolv
less
immunogen
exampl
aspect
must
function
receptor
recognit
requir
correspond
invari
structur
host
eg
epitop
buri
result
compar
less
immunogen
lead
product
rel
antibodi
natur
progress
diseas
isol
epitop
present
context
ie
immun
absenc
rest
viru
one
gain
desir
effect
enhanc
immunogen
produc
epitopebas
vaccin
deriv
conserv
aspect
viral
antigen
would
promis
focus
hope
function
protect
immun
also
effici
immun
respons
toward
gener
antibodi
respons
infect
alway
advantag
wherea
intent
immun
respons
neutral
pathogen
ultim
consequ
antibodi
produc
anticip
immun
system
thu
deleteri
effect
might
also
occur
two
type
undesir
effect
recogn
first
situat
gener
antibodi
noneffect
epitop
exampl
lead
infect
macrophag
due
fcreceptormedi
endocytosi
immunocomplex
pathogen
enhanc
antibodi
propos
mean
infect
via
altern
rout
via
back
door
propos
mechan
might
explain
independ
infect
epitopebas
vaccin
could
design
reduc
amount
ineffect
antibodi
infect
individu
thu
increas
specif
activ
neutral
antibodi
second
danger
mount
antibodi
pathogen
stem
possibl
epitop
mimet
nativ
host
protein
develop
autoimmun
connect
viral
infect
idea
event
foreign
antigen
structur
similar
nativ
host
protein
mount
antibodi
toward
similar
structur
may
lead
crossreact
bind
antibodi
autoantigen
lead
patholog
autoimmun
note
case
crossreact
detriment
compar
desir
effect
describ
previous
case
point
recent
describ
vaccin
develop
borrelia
burgdorferi
agent
caus
lyme
diseas
outer
surfac
protein
ospa
bacterium
contain
short
sequenc
nine
amino
acid
homolog
human
leukocyt
function
associ
result
lyme
vaccin
base
recombin
ospa
postul
induc
autoimmun
reaction
autoantigen
result
arthrit
symptom
target
delet
nonapeptid
epitop
ospa
propos
solut
problem
obvious
develop
epitopebas
vaccin
one
would
abl
ration
design
epitop
cocktail
exclud
epitop
could
associ
autoantigen
product
vaccin
technic
complic
biohazard
manufactur
requir
cultur
larg
volum
pathogen
moreov
pathogen
may
idiosyncrasi
translat
develop
custom
tailor
protocol
product
requir
specif
condit
reagent
assum
effect
epitopebas
vaccin
avail
product
perceiv
less
complic
much
safer
certainli
cheaper
long
run
discuss
first
step
develop
epitopebas
vaccin
identifi
epitop
obvious
epitop
correspond
ultim
immun
respons
desir
ie
broad
cross
neutral
bcn
genet
divers
pathogen
protect
requir
discoveri
epitop
could
serendipit
experiment
trial
error
howev
ration
design
vaccin
would
prefer
concept
backtrack
mab
proven
bcn
activ
seem
effici
mean
singl
epitop
candid
vaccin
product
epitop
defin
second
step
would
reconstitut
epitop
function
immunogen
number
consider
must
taken
account
first
bcell
epitop
oppos
tcell
epitop
often
discontinu
highli
conform
fact
even
event
signific
portion
epitop
short
linear
peptid
promis
peptid
repres
entir
epitop
requir
distinct
conform
recogn
even
short
linear
peptid
greatli
depend
three
dimension
conform
bioactiv
thu
exampl
presum
short
peptid
hormon
neurotransmitt
leu
metenkephalin
residu
angiotensin
ii
residu
substanc
p
residu
exempt
specif
conform
requir
physiolog
function
bcell
epitop
typic
compris
residu
deriv
discontinu
segment
antigen
brought
togeth
fold
produc
contigu
surfac
recogn
antibodi
task
reconstitut
effect
epitopebas
vaccin
must
take
fact
consider
attempt
posit
critic
contact
residu
proper
spatial
orient
mean
easi
task
final
reconstitut
epitop
could
either
base
actual
antigen
segment
tack
onto
support
scaffold
sort
altern
may
function
similar
epitop
structur
unrel
mimet
instanc
presum
function
moieti
epitop
effect
situat
space
use
altern
residu
chemistri
recreat
landscap
similar
epitop
use
composit
final
simpler
yet
less
comprehens
approach
would
attempt
reconstitut
partial
structur
element
epitop
exampl
epitop
compris
seri
antiparallel
strand
form
number
juxtapos
hairpin
one
might
consid
attempt
reconstruct
hairpin
separ
instead
tri
encompass
epitop
entireti
mimet
reconstitut
epitop
produc
third
step
develop
epitopebas
vaccin
would
produc
effect
immunogen
epitop
would
need
mount
onto
carrier
scaffold
one
would
confront
task
develop
effect
immun
scheme
consid
rout
immun
adjuv
immun
schedul
given
target
mab
exist
task
us
map
correspond
epitop
within
antigen
bind
simplest
case
major
element
epitop
may
linear
segment
antigen
isol
form
continu
bind
mab
detect
affin
discoveri
segment
accomplish
screen
mab
geysen
pepscan
mario
geysen
introduc
idea
gener
seri
overlap
linear
peptid
cover
entireti
antigen
studi
case
array
peptid
react
antibodi
segment
continu
bind
repres
signific
aspect
epitop
linear
peptid
test
capac
elicit
desir
effect
use
peptid
immunogen
pepscan
also
indic
compon
discontinu
epitop
event
two
distant
peptid
contain
suffici
structur
element
allow
bind
mab
separ
one
would
conclud
two
peptid
contribut
intact
epitop
type
analys
requir
solv
atom
structur
antigen
recent
year
classic
pepscan
incorpor
microarray
applic
exampl
see
cretich
et
al
poetz
et
al
use
high
throughput
system
well
multiplex
gold
standard
epitop
definit
becom
cocrystal
antigen
antibodi
complex
follow
solut
atom
structur
use
xray
diffract
analysi
system
highli
purifi
antigen
correspond
antibodi
allow
cocrystal
form
antigen
antibodi
complex
crystal
interrog
xray
due
highli
structur
repeat
natur
crystal
unit
diffract
pattern
gener
relat
fourier
transform
coordin
electron
densiti
amino
acid
compos
antigen
bound
antibodi
epitop
essenc
antigen
compon
antigen
antibodi
interfac
wherea
epitop
character
deriv
xray
crystallographi
spectacular
method
highli
sophist
tediou
demand
rather
caprici
hundr
thousand
antibodi
produc
year
uniqu
cocryst
gener
solv
illustr
except
low
overal
effici
techniqu
nonetheless
cocryst
obtain
one
assum
atom
structur
faith
repres
genuin
structur
antigen
antibodi
rel
orient
respect
one
anoth
defin
precis
interfac
ie
surfac
epitop
design
actual
contact
residu
matter
interpret
second
biophys
approach
toward
epitop
map
use
nuclear
magnet
reson
nmr
contrast
crystallographi
nmr
give
dynam
pictur
antigen
antibodi
complex
solut
structur
complex
result
atom
definit
antigen
antibodi
interfac
deriv
measur
effect
magnet
field
puls
electromagnet
radiat
proton
protein
complex
structur
deriv
specif
manner
proton
associ
amino
acid
absorb
electromagnet
radiat
sampl
subject
high
magnet
field
modul
absorb
spectrum
residu
caus
neighbor
residu
intens
effect
correl
distanc
residu
neighbor
thu
measur
distanc
angl
restraint
model
protein
gener
major
limit
method
asid
high
degre
sophist
demand
technic
expertis
expens
instrument
typic
restrict
rel
small
protein
kda
nonetheless
nmr
use
studi
bind
epitop
fragment
fab
one
learn
much
natur
epitop
recognit
gener
compar
structur
obtain
crystallographi
versu
nmr
one
conclud
two
method
complement
well
gener
similar
structur
although
differ
detail
exist
case
point
bind
carbohydratemimet
peptid
mdwnmhaa
anticarbohydr
antibodi
direct
opolysaccharid
shigella
flexneri
nmr
analys
would
indic
proton
ppm
residu
clearli
contact
antibodi
howev
support
crystal
structur
methyl
group
situat
away
residu
antibodi
hand
crystal
structur
strongli
suggest
design
residu
clear
contact
residu
yet
two
residu
show
absolut
enhanc
nmr
analys
argu
form
contact
ie
close
proxim
fab
thu
two
biophys
method
excel
delin
boundari
antigen
antibodi
interfac
definit
residu
actual
contribut
bind
degre
may
still
matter
controversi
less
demand
cocrystal
product
two
separ
crystal
structur
one
antigen
antibodi
satisfact
prerequisit
open
option
comput
dock
mean
epitop
discoveri
gener
abund
structur
isol
antibodi
fab
product
new
structur
either
experiment
comput
model
becom
reason
effici
thu
event
structur
obtain
antigen
question
gener
model
specif
correspond
antibodi
pose
problem
two
structur
exist
separ
batteri
comput
algorithm
exist
use
attempt
dock
silico
one
structur
onto
ultim
goal
dock
algorithm
determin
structur
complex
separ
determin
coordin
compon
kuntz
colleagu
came
first
wide
use
dock
program
name
dock
sinc
dock
field
flourish
mani
new
algorithm
dock
predict
base
assumpt
structur
complex
repres
lowest
free
energi
state
access
system
often
achiev
geometr
complementar
dock
algorithm
differ
method
use
gener
candid
solut
score
function
appli
evalu
search
method
classifi
three
categori
bruteforc
local
featur
algorithm
nondeterminist
method
panel
possibl
solut
gener
candid
solut
score
least
like
like
repres
genuin
complex
score
function
take
account
one
featur
shape
complementar
contact
area
hydrogen
bond
electrostat
interact
salvat
energi
etc
dock
predict
complet
two
question
formul
given
cours
experiment
coordin
genuin
complex
avail
rank
number
solut
closest
bonafid
complex
qualiti
solut
close
compar
genuin
interfac
although
consider
improv
achiev
score
function
still
weakest
compon
dock
algorithm
even
nearn
complex
found
necessarili
rank
one
top
score
solut
dock
procedur
success
small
molecul
dock
exampl
predict
enzymeinhibitorligand
complex
gener
rel
accur
result
case
small
molecul
rigid
correspond
bind
site
well
structur
pocket
close
follow
contour
ligand
neg
relief
complement
physicochem
requir
electrostat
charg
complement
neg
posit
charg
antibodyhapten
complex
also
reproduc
success
exampl
phosphocholin
bind
immunoglobulin
steroid
bind
antibodi
target
molecul
rigid
allow
one
introduc
flexibl
antibodi
bind
site
without
gener
infinit
number
solut
flexibl
bind
site
help
predict
conform
rearrang
occur
antibodi
recognit
compar
small
molecul
dock
protein
protein
interfac
rel
larg
partner
flexibl
tend
undergo
conform
chang
make
dock
extrem
difficult
fact
accur
result
best
obtain
start
point
two
alreadi
cocrystal
protein
structur
often
call
bound
dock
howev
unbound
dock
applic
involv
structur
separ
crystal
protein
also
call
predict
dock
yield
mani
falseposit
solut
theoret
good
surfac
complementar
score
extrem
high
actual
total
irrelev
nativ
complex
therefor
appear
wherea
comput
dock
method
extrem
attract
conceptu
case
antibodyantigen
dock
result
moment
less
satisfi
number
method
epitop
character
reli
function
bind
mab
antigen
deriv
one
approach
limit
scope
problem
epitop
map
test
abil
antibodi
continu
bind
fragment
antigen
thu
bind
assay
elisa
dot
blot
western
blot
assay
provid
insight
locat
epitop
within
gross
anatomi
antigen
exampl
epitop
mab
local
first
residu
cleavag
antigen
fragment
express
truncat
version
antigen
illustr
first
domain
antigen
bind
antibodi
similarli
systemat
biochem
analys
enzymat
degrad
subunit
nicotin
acetylcholin
receptor
use
synthet
peptid
express
fusion
protein
abl
local
ligand
bind
site
segment
subunit
receptor
contain
amino
acid
residu
principl
long
one
gener
fragment
continu
bind
one
attempt
identifi
smallest
segment
receptor
antigen
continu
recogn
thu
bind
per
se
serv
extrem
effect
monitor
presenc
function
aspect
epitop
exploit
oper
definit
epitop
segment
continu
bind
antibodi
number
experiment
strategi
employ
map
epitop
asm
alanin
walk
systemat
approach
mutagenesi
one
introduc
alanin
everi
residu
given
sequenc
one
time
posit
contain
alanin
origin
sequenc
usual
replac
glycin
thu
suspect
stretch
antigen
analyz
hope
identifi
specif
residu
critic
mab
recognit
asm
provid
import
inform
proteinbind
interfac
method
labori
mani
mutant
must
produc
purifi
evalu
regard
structur
integr
bind
constant
mutant
furthermor
asm
experi
interpret
result
confus
often
correspond
well
physic
bind
site
defin
crystallograph
studi
case
point
analysi
sever
acut
respiratori
syndrom
sar
coronaviru
spike
glycoprotein
receptor
bind
domain
rbd
complex
receptor
angiotensin
convert
enzym
ii
residu
rbd
subject
asm
six
found
compon
actual
bind
surfac
ultim
determin
cocrystal
total
exchang
inde
dramat
effect
rbd
bind
surprisingli
howev
three
actual
contact
residu
mention
thu
modif
three
residu
bind
site
impact
bind
moreov
remain
eight
mutat
profound
inhibitori
effect
bind
fact
situat
outsid
boundari
bind
surfac
goe
illustr
mutat
residu
outsid
bona
fide
epitop
result
loss
bind
possibl
impli
import
structur
integr
function
epitop
rather
role
contact
residu
per
se
structur
inform
avail
residu
would
mistakenli
assign
bind
epitop
altern
case
ar
interfac
mutat
bona
fide
contact
residu
alanin
necessarili
interfer
bind
anoth
exampl
antihel
hen
eggwhit
lysozym
antibodi
hel
interfac
turn
highli
toler
mutat
alanin
mutat
contact
residu
determin
cocryst
hel
significantli
reduc
antibodi
bind
altern
mutat
critic
contact
residu
ala
result
loss
one
hydrogen
bond
seven
van
der
waal
contact
antibodi
impact
bind
explain
fact
three
water
molecul
fill
void
creat
substitut
ala
therefor
compens
lack
function
asp
moieti
allow
bind
activ
persist
indic
mani
residu
compris
epitop
absolut
critic
interact
provid
essenti
contact
requir
antibodi
recognit
result
absenc
cocryst
contact
residu
toler
mutat
would
includ
predict
epitop
mutat
also
direct
target
fashion
name
base
assumpt
potenti
involv
given
residu
area
antigen
mab
bind
one
systemat
construct
mutat
specif
test
effect
alter
select
residu
exampl
order
local
fab
epitop
residu
select
alanin
exchang
mutagenesi
direct
structur
inform
epitop
recogn
compet
antibodi
mutant
construct
eight
result
signific
reduct
antibodi
bind
subsequ
crystal
structur
solv
becam
appar
substitut
made
residu
fell
within
genuin
bind
epitop
nonetheless
six
alanin
mutat
four
effect
bind
predict
part
epitop
wherea
two
mutat
impair
bind
significantli
moreov
six
mutat
outsid
epitop
signific
effect
antibodi
bind
realiz
major
mutat
affect
bind
actual
part
genuin
epitop
altern
asm
satur
mutagenesi
less
systemat
approach
introduc
singl
residu
modif
technic
number
method
use
randomli
insert
mutat
throughout
sequenc
antigen
one
method
product
peptid
limit
number
mutat
per
molecul
bias
random
mutagenesi
techniqu
correspond
oligonucleotid
synthes
use
phosphoramidit
monom
precursor
contamin
regul
amount
three
nucleotid
precursor
degre
contamin
phosphoramidit
need
achiev
desir
mutat
frequenc
per
peptid
calcul
use
algorithm
describ
ophir
gershoni
random
mutat
also
achiev
use
chemic
reagent
sodium
bisulfit
hydroxylamin
nitrou
acid
reagent
induc
structur
modif
specif
base
dna
sequenc
result
altern
base
pair
thu
chang
dna
sequenc
addit
chemic
reagent
formic
acid
hydrazin
capabl
damag
dna
base
thu
prevent
watsoncrick
pair
ultim
caus
misincorpor
nucleotid
errorpron
polymeras
chain
reaction
pcr
wide
use
mutagenesi
techniqu
implement
use
lowfidel
dna
polymeras
effici
introduc
random
mutat
along
amplifi
sequenc
whatev
method
ultim
goal
randomli
cover
surfac
antigen
mutat
score
mab
bind
inhibit
bind
taken
indic
role
origin
residu
mutat
antibodi
recognit
thu
epitop
map
stem
identif
cluster
mutat
strongli
affect
mab
bind
problem
mutat
contact
residu
alway
result
loss
mab
bind
moreov
loss
bind
often
result
modif
residu
lie
outsid
epitop
instanc
degre
success
random
mutagenesi
mean
predict
epitop
determin
studi
crystal
structur
histidin
phosphocarri
protein
hpr
mab
complex
among
random
mutat
made
surfac
hpr
contact
residu
defin
cocryst
thirteen
mutat
result
reduct
mab
bind
nine
residu
lay
within
genuin
bind
epitop
howev
remain
four
inhibitori
mutat
residu
total
remov
bind
interfac
furthermor
mutat
three
bona
fide
contact
residu
virtual
effect
bind
indic
substitut
epitoperesidu
often
accommod
summari
target
random
mutagenesi
easili
perform
method
often
gener
dramat
effect
mab
bind
mutat
antigen
howev
view
fact
mutat
contact
residu
either
inhibit
bind
enhanc
bind
effect
interpret
mutagenesi
experi
confus
residu
outsid
area
epitop
also
impact
mab
bind
thu
epitop
predict
mutagenesi
best
consid
caution
phage
display
librari
random
peptid
construct
use
phage
display
vector
short
oligonucleotid
eg
base
correspond
six
codon
creat
hexapeptid
clone
end
either
protein
protein
gene
phage
random
natur
produc
allow
posit
oligonucleotid
assum
four
base
gatc
manner
possibl
combin
base
consequ
amino
acid
express
phage
thu
display
peptid
code
singl
strand
genom
physic
linkag
peptid
genet
code
allow
one
affin
isol
phage
bind
mab
interest
elucid
sequenc
peptid
standard
dna
sequenc
year
numer
phage
display
peptid
librari
produc
use
extens
character
bcell
epitop
gener
procedur
straightforward
mab
analyz
immobil
solid
surfac
react
comprehens
librari
random
peptid
usual
order
differ
peptid
typic
residu
long
may
may
disulfid
constrain
process
coin
biopan
result
random
peptid
resembl
mab
epitop
manner
bound
immobil
mab
other
wash
away
affin
bound
phage
collect
peptid
sequenc
determin
sequenc
affin
purifi
phage
correspond
linear
stretch
antigen
epitop
map
becom
self
evid
howev
gener
one
obtain
collect
phage
necessarili
resembl
antigen
situat
one
assum
phage
specif
bind
mab
reflect
epitop
fashion
mapitop
novel
comput
algorithm
predict
discontinu
bcell
epitop
base
notion
panel
peptid
deriv
random
peptid
librari
collect
repres
epitop
mab
bind
underli
principl
mapitop
simplest
meaning
fragment
epitop
amino
acid
pair
aap
residu
lie
within
footprint
epitop
aap
relat
one
anoth
surfac
antigen
cluster
pair
defin
constitut
major
epitop
footprint
ie
predict
epitop
essenc
cluster
connect
aap
aap
epitop
need
consecut
tandem
residu
antigen
often
result
juxtaposit
distant
residu
brought
togeth
fold
polypeptid
chain
aap
epitop
simul
tandem
residu
peptid
affin
select
random
librari
order
identifi
meaning
aap
present
panel
peptid
peptid
deconvolut
pair
exampl
peptid
sequenc
would
written
seri
pair
ab
bc
cd
de
etc
aap
deriv
panel
peptid
pool
frequenc
type
calcul
determin
whether
represent
pool
higher
random
expect
base
theoret
amino
acid
frequenc
phage
librari
signific
aap
consid
statist
signific
pair
ssp
thu
peptid
assum
contain
one
epitoperelev
aap
basi
mab
recognit
peptid
figur
demonstr
fundament
concept
algorithm
role
ssp
mab
recognit
note
mutat
residu
member
ssp
greatli
impact
antibodi
bind
wherea
alter
residu
part
ssp
affect
bind
compil
list
ssp
algorithm
seek
pair
surfac
antigen
attempt
link
cluster
see
figur
tarnovitski
et
al
summari
mab
use
screen
random
peptid
librari
gener
panel
affin
select
peptid
peptid
deconvolut
aap
ssp
identifi
ssp
map
surfac
atom
structur
antigen
elabor
divers
cluster
identifi
regard
predict
epitop
candid
backtrack
mab
correspond
epitop
provid
mean
ration
design
vaccin
use
epitopebas
vaccin
although
yet
implement
commerci
prove
effect
case
obviat
problem
exist
tradit
vaccin
paradigm
henc
first
real
challeng
develop
epitopebas
vaccin
abl
identifi
epitop
interest
reason
precis
undoubtedli
effect
mean
physic
xray
analysi
antigen
antibodi
cocryst
howev
often
easili
achiev
empir
approach
describ
certainli
readili
access
yet
advantag
disadvantag
prospect
use
combinatori
approach
select
mabspecif
peptid
analyz
via
comput
algorithm
mapitop
seem
promis
epitop
identifi
understood
atom
level
next
step
challeng
reconstitut
gener
effect
immunogen
hope
initi
step
becom
routin
epitopebas
vaccin
abl
contribut
long
tradit
vaccin
better
human
health
